MCT System · Preset

MCT Plasma

Stimulates platelets and boosts growth factor release, resulting in faster and better outcomes.

Contact usHow it worksScientific evidence

Red light
With controlled cold

Primed platelets
Sustained growth factor release

Autologous
PRP at the point of care

What it does

Platelets primed by light and cold.

Growth factor release

Photothermally boosted platelets release a higher amount of growth factors in a controlled and sustained way, for a more physiological effect.

Platelet performance

Photothermally stimulated plasma contains fewer pro-inflammatory cytokines and has a more physiological profile. It also improves the platelet activation profile, reducing VASP and increasing p38 phosphorylation. Cold primes platelets and facilitates their reactivity once injected.

Procedure comfort

Cold helps platelet kinetics after activation, not before, and induces a delay in clot formation. A less dense plasma and the sensation of the cold liquid result in a much more comfortable procedure.

ATP synthesis

Photothermal biomodulation boosts cellular metabolism and enhances ATP synthesis.

The technology

Photothermal biomodulation

Red light and controlled cold, applied to the patient’s own platelet-rich plasma inside the MCT Kit®.

Light · 620 nm

Photobiomodulation

Light provides a non-invasive, non-toxic way of stimulating cellular metabolism. Ultimately, the energy absorbed at the mitochondria enhances cellular ATP production.

Photothermal stimulation of PRP generates a state-of-the-art regenerative preparation. It achieves improved clinical results due to a more prolonged and sustained growth factor release and a reduced pro-inflammatory cytokine content.

Temperature · 4 °C

Thermal biomodulation

As with light, temperature has a huge body of evidence that backs up its effectiveness and safe utilization. Thermal stimulation prepares platelets to work more and better, increases their reactiveness and shows a myriad of activation markers. Primed platelet functionality also determines an increase in growth factors.

Since thermal boosting delays clot onset and primes platelet aggregation only after activation, the result is a less dense regenerative product, improving clinical results with a more convenient injection experience.

Autologous biological products

From medical need to medical solution

The patient’s own blood, processed at the point of care.

MCT Academy

Published research on photothermal PRP

Scientific publications and case reports on photothermally conditioned platelet-rich plasma, from bench to clinical practice.

All publicationsWatch the webinars
Protocol for ex vivo physicochemical assessment of photothermally preconditioned platelet-rich plasma
Protocol for ex vivo physicochemical assessment of photothermally preconditioned platelet-rich plasmaMCT PublicationsRegenerative Medicine

Protocol for ex vivo physicochemical assessment of photothermally preconditioned platelet-rich plasma

MethodsX · 2026 — Laura Cordero, Elena Sánchez-Vizcaíno Mengual, Hernán Pinto
Photothermal preconditioning of platelet-rich plasma: An emerging regenerative strategy
Photothermal preconditioning of platelet-rich plasma: An emerging regenerative strategyMCT PublicationsRegenerative Medicine

Photothermal preconditioning of platelet-rich plasma: An emerging regenerative strategy

Regenerative Therapy · 2026 — Elena Sánchez-Vizcaíno Mengual, Laura Cordero, Hernán Pinto
Novel use of preconditioned autologous PRP-derived exosomes for partial Achilles tendon rupture repair: A three-week recovery case report
Novel use of preconditioned autologous PRP-derived exosomes for partial Achilles tendon rupture repair: A three-week recovery case reportMCT PublicationsOrthopedics

Novel use of preconditioned autologous PRP-derived exosomes for partial Achilles tendon rupture repair: A three-week recovery case report

Journal of Orthopaedic Reports · 2025 — Alberto Sánchez Herrera

GET IN TOUCH

Meta Cell Technology. Advancing what matters in care.

Connect with us